{"disease":{"id":"adenoviral-infection","name":"adenoviral infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03160339","title":"A Study to Assess the Safety, Pharmacodynamics, and Immunogenicity of PXVX0047","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"Emergent BioSolutions","has_results":false},{"nct_id":"NCT01945619","title":"Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Baylor College of Medicine","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}